Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0671430B2 - Method for producing β-1,3-glucan by Euglena cells - Google Patents
[go: Go Back, main page]

JPH0671430B2 - Method for producing β-1,3-glucan by Euglena cells - Google Patents

Method for producing β-1,3-glucan by Euglena cells

Info

Publication number
JPH0671430B2
JPH0671430B2 JP21548486A JP21548486A JPH0671430B2 JP H0671430 B2 JPH0671430 B2 JP H0671430B2 JP 21548486 A JP21548486 A JP 21548486A JP 21548486 A JP21548486 A JP 21548486A JP H0671430 B2 JPH0671430 B2 JP H0671430B2
Authority
JP
Japan
Prior art keywords
glucan
cells
euglena
euglena cells
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP21548486A
Other languages
Japanese (ja)
Other versions
JPS6371192A (en
Inventor
知広 佐藤
歳満 藤本
信次 山西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Gas Co Ltd
Original Assignee
Osaka Gas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka Gas Co Ltd filed Critical Osaka Gas Co Ltd
Priority to JP21548486A priority Critical patent/JPH0671430B2/en
Publication of JPS6371192A publication Critical patent/JPS6371192A/en
Publication of JPH0671430B2 publication Critical patent/JPH0671430B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Description

【発明の詳細な説明】 産業上の利用分野 本発明は、ユーグレナ細胞によるβ−1,3−グルカン
(パラミロン)の製造方法に関する。
TECHNICAL FIELD The present invention relates to a method for producing β-1,3-glucan (paramylon) by Euglena cells.

従来技術とその問題点 近年、栄養学的観点から、ユーグレナ細胞が注目されて
いる。即ち、ユーナゲル細胞に含まれる蛋白質のアミノ
酸構成が、乳蛋白質であるカゼインと類似し、且つ消化
率が高く、ラットによる実験結果から、その生物価、正
味の蛋白質利用効率もカゼインとほぼ同等であり、また
従来から研究されている藻類、クロレラ、スピルリナ等
に比べて、これらの価に優れていると報告されている
(北岡、細谷;農化誌,51(8),477〜482(1977):ib
id;農化誌、51(8)、483〜488(1977))。また、水
産養殖における種苗生産のため、ユーグレナ細胞を幼稚
魚に与えた結果の検討も行なわれている。特に、ユーグ
レナ細胞に高い含有率で含まれるビタミン類や脂肪酸組
成に見出されるω3系列の高度不飽和脂肪酸が、幼稚魚
の飼料として有用であろうことが指摘されている(佐
藤、吉中;水産増殖、32(2)、88〜91(1984))。
Conventional technology and its problems In recent years, Euglena cells have been attracting attention from a nutritional viewpoint. That is, the amino acid composition of the protein contained in Eunagel cells is similar to that of milk protein, casein, and has a high digestibility, and the biological value and the net protein utilization efficiency are almost the same as those of casein from the results of experiments by rats. In addition, it is reported that they are superior in value to algae, chlorella, spirulina, etc., which have been conventionally studied (Kitaoka, Hosoya; Agricultural Journal, 51 (8), 477-482 (1977). : ib
id; Agricultural magazine, 51 (8), 483-488 (1977)). In addition, for the production of seedlings in aquaculture, the results of feeding euglena cells to juvenile fish are also being examined. In particular, it has been pointed out that the highly unsaturated fatty acids of the ω3 series found in the vitamins and fatty acid composition contained in Euglena cells at a high content may be useful as a feed for juvenile fish (Sato, Yoshinaka; Aquaculture) , 32 (2), 88-91 (1984)).

しかしながら、これらの栄養学的研究および検討は、全
てユーグレナの細胞に含まれる蛋白質や微量成分である
ビタミン類、脂肪酸などに着目したものであり、ユーグ
レナ細胞が、特異的に蓄積するβ−1,3−グルカンの収
量増大に関する研究はなされていない。
However, all of these nutritional studies and studies are focused on proteins and trace components such as vitamins and fatty acids contained in Euglena cells, and β-1, which Euglena cells specifically accumulate, No studies have been done on increasing the yield of 3-glucan.

従来から、β−1,3−グルカンの食物とての生理学的有
用性及び免疫活性賦活剤としての免疫学的有用性は、報
告されている(水野、坂村、:化学と生物、23(12)、
797〜802(1986))が、これに報告されている生産方法
は、管理の厄介な細胞類及び栽培に長期を要する担子菌
を使用する方法であるため、β−1,3−グルカンの生産
効率は、低く、従って製造費が高価となる。
The physiological usefulness of β-1,3-glucan as a food and the immunological usefulness as an immunostimulator have been reported (Mizuno, Sakamura, Chemistry and Biology, 23 (12). ),
797-802 (1986)), the production method reported in this method uses cells that are difficult to manage and basidiomycetes that require a long period of time for cultivation. Therefore, β-1,3-glucan is produced. The efficiency is low and therefore expensive to manufacture.

また、ユーグレナ細胞中に蓄積多糖類としてβ−1,3−
グルカンが含まれていることは知られていたが、従来の
培養フラスコによる方法では、乾燥細胞重量に対するβ
−1,3−グルカンの含有率は70%程度、培地炭素量当り
のβ−1,3−グルカンの生産量は、炭素1g当り僅か0.83g
程度であった。
In addition, as a polysaccharide that accumulates in Euglena cells, β-1,3-
Although it was known to contain glucan, the conventional culture flask method used to
The content of -1,3-glucan is about 70%, and the production of β-1,3-glucan per medium carbon amount is only 0.83g per 1g carbon.
It was about.

問題点を解決する為の手段 本発明者等は、従来から、ユーグレナ細胞の有用性に着
目して種々研究を重ねてきた。その結果として、蛋白質
含有量を高めたユーグレナ細胞の培養方法を完成し、既
に特許出願中である(特願昭60−160044号)。本発明者
は、更に研究を進めるうちに、培地における炭素濃度、
炭素と窒素との比、培地のpH、温度及び溶存酸素濃度等
を特定の価に調整することにより、ユーグレナ細胞の収
量及びユーグレナ細胞中のβ−1,3−グルカン含有率を
高め、以てβ−1,3−グルカンの生産効率を飛躍的に高
め得ることを見出した。即ち、本発明は、初発の培地中
の炭素濃度を2〜12g/、炭素と窒素の原子量比(C/
N)を10〜30、増殖時のpHを3〜6、温度を25〜34℃、
溶存酸素濃度を0.1〜1ppmとし、ユーグレナ細胞を培養
することを特徴とするユーグレナ細胞によるβ−1,3−
グルカンの製造方法に係る。
Means for Solving the Problems The inventors of the present invention have conventionally conducted various studies focusing on the usefulness of Euglena cells. As a result, a method for culturing Euglena cells with an increased protein content has been completed, and a patent has already been applied (Japanese Patent Application No. 60-160044). The present inventor, while further researching, the carbon concentration in the medium,
By adjusting the ratio of carbon and nitrogen, pH of the medium, temperature, dissolved oxygen concentration, etc. to specific values, the yield of Euglena cells and the β-1,3-glucan content in Euglena cells are increased, and It was found that the production efficiency of β-1,3-glucan can be dramatically increased. That is, the present invention, the carbon concentration in the initial medium 2-12g /, the atomic weight ratio of carbon and nitrogen (C /
N) 10-30, pH during growth 3-6, temperature 25-34 ℃,
Β-1,3-by Euglena cells characterized by culturing Euglena cells with a dissolved oxygen concentration of 0.1-1 ppm
The present invention relates to a method for producing glucan.

本発明方法は、ユーグレナ・グラシリス、ユーグレナ・
ビリデ、ユーグレナ・インタミディア等のユーグレノイ
ド、河川、糊沼等に生育する野生株等のユーグレナ属の
いかなる種にも適用される。
The method of the present invention comprises Euglena gracilis, Euglena
It can be applied to any species of the genus Euglena such as euglenaids such as viridae and euglena intermedia, and wild strains that grow in rivers and marshlands.

本発明で使用する培地成分は、通常のものでよく、例え
ば、炭素源として単糖類、二糖類、廃糖蜜、コーンスタ
ーチ、酵母エキス等の糖類;アミノ酸、酢酸、クエン
酸、コハク酸、リンゴ酸、乳酸等の有機酸類;メタノー
ル、エタノール等のアルコール類及び炭酸ガス等が用い
られ、窒素源として硫酸アンモニウム、リン酸アンモニ
ウム、アミノ酸類等が用いられる。また、無機塩類とし
てはMgSO4、MgCO3、MgCl2、CaCO3、KH2PO4、Na2EDTA、F
eSO4(NH42SO4、MnSO4、ZnSO4、(NH46Mo7O24、CuS
O4、NH4VO3、CoSO4、H3BO3、NiSO4等またはこれら無機
塩の水和物等が用いられる。ビタミンとしては、シアノ
コバラミン、チアミン塩酸等が用いられる。この様な培
地の代表例を第1表に示す。
The medium components used in the present invention may be ordinary ones, for example, monosaccharides as carbon sources, disaccharides, molasses, corn starch, saccharides such as yeast extract; amino acids, acetic acid, citric acid, succinic acid, malic acid, Organic acids such as lactic acid; alcohols such as methanol and ethanol and carbon dioxide gas are used, and ammonium sulfate, ammonium phosphate, amino acids and the like are used as nitrogen sources. Further, as inorganic salts, MgSO 4 , MgCO 3 , MgCl 2 , CaCO 3 , KH 2 PO 4 , Na 2 EDTA, F
eSO 4 (NH 4 ) 2 SO 4 , MnSO 4 , ZnSO 4 , (NH 4 ) 6 Mo 7 O 24 , CuS
O 4 , NH 4 VO 3 , CoSO 4 , H 3 BO 3 , NiSO 4, etc. or hydrates of these inorganic salts are used. As the vitamin, cyanocobalamin, thiamine hydrochloric acid and the like are used. A typical example of such a medium is shown in Table 1.

本発明では、回分式における初発の培地中の炭素濃度を
2〜12g/、炭素と窒素との原子量比(C/N)を10〜30
とし、その他の成分濃度は、通常使用されている培地の
濃度と同様として、滅菌した後、ユーグレナの種細胞を
植種して培養を開始する。初発の培地中の炭素濃度が、
2g/未満では、炭素量が不充分であり、培養安定期に
おける細胞濃度が15〜20×166個/mlに達しない。一方、
12g/を上回る場合には、殺菌後の培地成分の変性が認
められ、細胞増殖が著しく阻害される。C/N比が10未満
の場合には、β−1、3−グルカンの蓄積含有率が低く
なり、30を上回る場合には、細胞の増殖が低下する。植
種する細胞の濃度は、1×105〜1×106個/ml程度であ
り、植種後4〜5日程度で安定期に達する。植種する細
胞数が多い程短時間内に安定期に達する。細胞種は、β
−1、3−グルカンを蓄積する代謝系を有するものであ
れば、野生株及び変異株のいかんを問わない。培養中の
培地pHは約3〜6とする。pHが3未満の場合には、細胞
の増殖が低下するとともにβ−1、3−グルカンの含有
量が低下し、6を超えると、β−1、3−グルカンの含
有率は高くなるが、細胞の増殖が不良となる。pHの調整
は、塩酸、硫酸等の酸または水酸化ナトリウム、水酸化
カリウム、水酸化カルシウム、アンモニア水等のアルカ
リ剤により行なう。培養中の温度は、24〜34℃とする。
温度が、24〜34℃の範囲外となる場合には、やはりユー
グレナ細胞の生育が阻害される。培養温度は、30℃前後
が特に好適である。培養中の酸素濃度は(以下DOとす
る)は、0.1〜1ppmの範囲とすることが必要である。DO
が0.1ppmよりも低いと、呼吸作用に及ぼす酸素濃度低下
のためにユーグレナ細胞の増殖がほとんど行なわれず、
一方1ppmを上回る場合には、細胞内のβ−1、3−グル
カン生成量が減少し、蛋白質の生成量が増大する。酸素
は、空気または酸素ガスを通気することにより供給す
る。
In the present invention, the carbon concentration in the initial medium in the batch system is 2 to 12 g /, and the atomic weight ratio of carbon and nitrogen (C / N) is 10 to 30.
The concentrations of the other components are the same as those of the medium that is usually used, and after sterilization, seed cells of Euglena are seeded and the culture is started. The carbon concentration in the initial medium is
It is less than 2 g /, is insufficient carbon amount, the cell concentration in the culture stable period does not reach 15 to 20 × 16 6 cells / ml. on the other hand,
If it exceeds 12 g /, denaturation of the medium components after sterilization is observed, and cell growth is significantly inhibited. When the C / N ratio is less than 10, the cumulative content of β-1,3-glucan is low, and when it exceeds 30, the cell proliferation is decreased. The concentration of cells to be inoculated is about 1 × 10 5 to 1 × 10 6 cells / ml, and a stable period is reached about 4 to 5 days after the inoculation. As the number of cells to be seeded increases, the stable period is reached within a short time. The cell type is β
As long as it has a metabolic system that accumulates -1,3-glucan, it does not matter whether it is a wild strain or a mutant strain. The pH of the medium in the culture is about 3-6. When the pH is less than 3, the proliferation of cells decreases and the content of β-1,3-glucan decreases, and when the pH exceeds 6, the content of β-1,3-glucan increases, Poor cell growth. The pH is adjusted with an acid such as hydrochloric acid or sulfuric acid or an alkaline agent such as sodium hydroxide, potassium hydroxide, calcium hydroxide or aqueous ammonia. The temperature during culture is 24 to 34 ° C.
When the temperature is outside the range of 24 to 34 ° C, the growth of Euglena cells is also inhibited. A culture temperature of about 30 ° C. is particularly suitable. The oxygen concentration in the culture (hereinafter referred to as DO) needs to be in the range of 0.1 to 1 ppm. DO
Is less than 0.1 ppm, Euglena cells are hardly proliferated due to a decrease in oxygen concentration that affects respiratory action,
On the other hand, when it exceeds 1 ppm, intracellular β-1,3-glucan production decreases and protein production increases. Oxygen is supplied by aerating air or oxygen gas.

培養は、出来るだけ暗黒状態で行なうことが望ましい。
光照度が、増大すると、光合成機能が活発となって、蛋
白質生成量が増大し、相対的にβ−1、3−グルカンの
生成量が減少する。
It is desirable to carry out the culture in the darkest possible state.
When the light illuminance increases, the photosynthetic function becomes active, the amount of protein produced increases, and the amount of β-1,3-glucan produced decreases relatively.

発明の効果 本発明によれば、乾燥ユーグレナ細胞基準で、75〜83%
程度のβ−1、3−グルカンが得られ、また培地炭素量
1g当りβ−1、3−グルカン生成量は1.15〜1.25g程度
にも達する。
EFFECTS OF THE INVENTION According to the present invention, 75-83% on the basis of dry Euglena cells
The degree of β-1,3-glucan was obtained, and the amount of carbon in the medium was
The amount of β-1,3-glucan produced per gram reaches about 1.15 to 1.25 g.

実施例 以下に実施例及びを示し、本発明の特徴とするところを
より一層明らかにする。
Examples Hereinafter, examples and will be shown to further clarify the features of the present invention.

実施例1 下記第2表に示す条件下に暗黒状態でユーグレナ・グラ
シリスの培養を行なった。なお、植種細胞数は、1×10
5個/mlであった。植種4日後の結果を第3表に示す。
Example 1 Euglena gracilis was cultured in the dark under the conditions shown in Table 2 below. The number of seeded cells is 1 x 10
It was 5 / ml. The results 4 days after planting are shown in Table 3.

第2表および第3表に於いて、No.1は、ストレプトマイ
シン処理によるコーグレナ・グラシリス変異株を使用し
た結果(北岡、細谷;農化誌,51(8),477〜482(197
7):ibid;農化誌、51(8)、483〜488(1977))であ
り、従来最高のβ−1、3−グルカン生産効率をしめす
とされている方法である。また、No.3、5、7、9、10
及び11は、培養条件のいずれかが、本発明の範囲外とな
っている方法である。本発明による方法No.2、4、6及
び8において、優れた効果が得られていることが明らか
である。
In Tables 2 and 3, No. 1 is the result of using a Streptomycin-treated Cogrena gracilis mutant strain (Kitaoka, Hosoya; Agricultural Journal, 51 (8), 477-482 (197).
7): ibid; Agricultural Journal, 51 (8), 483 to 488 (1977)), which is a method that is said to show the highest β-1,3-glucan production efficiency in the past. Also, No. 3, 5, 7, 9, 10
And 11 are methods in which any one of the culture conditions is outside the scope of the present invention. It is clear that excellent effects are obtained in the methods Nos. 2, 4, 6 and 8 according to the present invention.

実施例2 実施例1の第2表のNo.4の方法において、DOを変更する
以外は、同様の条件下に培養を行なった。
Example 2 In the method of No. 4 in Table 2 of Example 1, culture was performed under the same conditions except that DO was changed.

結果は、第1図に示す通りである。第1図において曲線
(A)はβ−1、3−グルカンの生成量を、曲線(B)
は蛋白質の生成量を、曲線(C)は脂質の生成量を夫々
示す。DOが0.1〜1ppmの範囲で特にβ−1、3−グルカ
ンの生成量が大きく、DOが増大するに従って、その量
は、急速に減少している。
The results are as shown in FIG. In FIG. 1, the curve (A) shows the amount of β-1,3-glucan produced, and the curve (B) shows
Represents the amount of protein produced, and curve (C) represents the amount of lipid produced. The production amount of β-1,3-glucan is particularly large in the DO range of 0.1 to 1 ppm, and the amount thereof rapidly decreases as the DO amount increases.

【図面の簡単な説明】[Brief description of drawings]

第1図は、培地中の溶存酸素量とβ−1,3、グルカンの
生成量との関係を示すグラフである。
FIG. 1 is a graph showing the relationship between the amount of dissolved oxygen in the medium and the amounts of β-1,3 and glucan produced.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】初発の培地中の炭素濃度を2〜12g/、炭
素と窒素の原子量比(C/N)を10〜30、増殖時のpHを3
〜6、温度を25〜34℃、溶存酸素濃度を0.1〜1ppmと
し、ユーグレナ細胞を培養することを特徴とするユーグ
レナ細胞によるβ−1,3−グルカンの製造方法。
1. The initial concentration of carbon in the medium is 2 to 12 g /, the atomic ratio of carbon and nitrogen (C / N) is 10 to 30, and the pH during growth is 3
-6, the temperature is 25 to 34 ° C, the dissolved oxygen concentration is 0.1 to 1 ppm, and Euglena cells are cultured, and a method for producing β-1,3-glucan by Euglena cells.
JP21548486A 1986-09-11 1986-09-11 Method for producing β-1,3-glucan by Euglena cells Expired - Lifetime JPH0671430B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21548486A JPH0671430B2 (en) 1986-09-11 1986-09-11 Method for producing β-1,3-glucan by Euglena cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21548486A JPH0671430B2 (en) 1986-09-11 1986-09-11 Method for producing β-1,3-glucan by Euglena cells

Publications (2)

Publication Number Publication Date
JPS6371192A JPS6371192A (en) 1988-03-31
JPH0671430B2 true JPH0671430B2 (en) 1994-09-14

Family

ID=16673147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21548486A Expired - Lifetime JPH0671430B2 (en) 1986-09-11 1986-09-11 Method for producing β-1,3-glucan by Euglena cells

Country Status (1)

Country Link
JP (1) JPH0671430B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130303752A1 (en) * 2012-05-07 2013-11-14 Algal Scientific Corporation Multi-stage process for production of immune modulator

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
US4946450A (en) * 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
DE4220889A1 (en) * 1992-06-25 1994-02-24 Mueller Karl & Co Kg Reactivation mixture for starter cultures for raw sausage production
CN118542382A (en) * 2024-06-12 2024-08-27 长江大学 New use of euglena powder in finless eel culture
CN120818441B (en) * 2025-09-18 2025-12-09 北京藻辰生物科技有限公司 Euglena gracilis strain capable of producing beta-1, 3-glucan at high yield and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130303752A1 (en) * 2012-05-07 2013-11-14 Algal Scientific Corporation Multi-stage process for production of immune modulator
US9574217B2 (en) * 2012-05-07 2017-02-21 Algal Scientific Corporation Multi-stage process for production of immune modulator

Also Published As

Publication number Publication date
JPS6371192A (en) 1988-03-31

Similar Documents

Publication Publication Date Title
US4551164A (en) Microbial plant growth promoter
US2890989A (en) Method for the production of carotenes
JP2005176851A (en) Docosahexaenoic acid and compound containing docosahexaenoic acid
TWI878535B (en) Method of preparing biomass including proteins and omega-3 fatty acids from single microalgae, and biomass prepared thereby
CA2312209A1 (en) Aqueous lysine-containing animal feed supplements and process for the production thereof
CN107760612A (en) A kind of aspergillus niger yy07 bacterial strains and its application in solid fermentation produces feeding acid protease
DE2452502A1 (en) METHOD FOR BREEDING AETHANOLASSIMILATING YEAST
JPH0671430B2 (en) Method for producing β-1,3-glucan by Euglena cells
DE2824390C2 (en)
DE2401519A1 (en) MICROBIOLOGICAL PROCESS FOR THE PRODUCTION OF LIQUID AND DRY FEED CONCENTRATES OF L-LYSINE AND CRYSTALLINE L-LYSINE
JPS63123392A (en) Production of hyaluronic acid
CS220315B2 (en) Method of producing bacterial cells
US3001912A (en) Process for the production of beta-carotene
DE2342912C2 (en) Production of L-histidine
CN110669757A (en) Production method of zinc-rich yeast with high zinc methionine content
EP0248238B1 (en) Process for the preparation by fermentation of l-isoleucine from d,l-alpha-hydroxybutyrate
JPH0532020B2 (en)
US4892960A (en) Crystalline lysocellin compositions and method of making
US2965545A (en) Production of lysine
JP2000166417A (en) High-density culture method of rotifers
CN1044497A (en) The microbial detoxification method of cottonseed cake
JPH03183474A (en) High-content arginine-containing yeast
JP2025505439A (en) High-protein microalgal biomass with excellent pepsin digestibility, cultivation method and use thereof
CN105506047A (en) Method for preparing polypepetide from oil peony meal
JPH0789875B2 (en) Rotifer feed